Clinical trial
Pilot Study: Evaluating the Effect of 300 Micrograms Testosterone Patches in Addition to Hormone Replacement Therapy on Arterial Compliance, Insulin Resistance and Sexual Desire.
NCT01208038 is registered in ClinicalTrials.gov with Imperial College Healthcare NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study: Evaluating the Effect of 300 Micrograms Testosterone Patches in Addition to Hormone Replacement Therapy on Arterial Compliance, Insulin Resistance and Sexual Desire.
- Lead sponsor
- Imperial College Healthcare NHS Trust
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- February 29, 2012
- Enrollment
- 22 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hypoactive sexual desire disorder